Althea CEO blames Covid and TGA for demise of pharma division by Steve Jones May 20, 2025May 20, 2025 Althea Group Holding’s ambitions to become a leader in the global medicinal cannabis industry were scuppered […]
Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors by Steve Jones March 21, 2025March 26, 2025
Althea claims profitability ‘is close’ despite pharmaceutical nosedive by Steve Jones March 3, 2025March 4, 2025
Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO by Steve Jones February 20, 2025February 20, 2025
Althea resumes trading on ASX as board narrowly avoids a second shareholder revolt by Steve Jones February 3, 2025February 3, 2025
Althea reports cash flow positive quarter but shaves top end of revenue guidance by Steve Jones October 31, 2024February 25, 2025
Impairment charge sees Althea losses sink to $32m despite revenue growth by Steve Jones August 30, 2024September 2, 2024
Althea shares tumble after announcing $2m capital raise for product expansion by Steve Jones July 16, 2024July 17, 2024
Pathway to profitability ‘hugely tough’, but Althea boss keeps the faith by Steve Jones May 28, 2024May 29, 2024
Althea makes further savings as cost-cutting program continues by Steve Jones April 30, 2024April 30, 2024
